Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B McCall

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivativesC H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonistM F Piercey, A H Tang, R A Lahti, et al.
Journal of Medicinal Chemistry|June 19, 1998
Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effectsM D Ennis, N B Ghazal, R L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonistK M Merchant, G S Gill, D W Harris, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivativesC H Lin, S R Haadsma-Svensson, G Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonistM F Piercey, A H Tang, R A Lahti, et al.
Journal of Medicinal Chemistry|June 19, 1998
Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effectsM D Ennis, N B Ghazal, R L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonistK M Merchant, G S Gill, D W Harris, et al.
Pageof 10